1. Home
  2. BLRX vs COE Comparison

BLRX vs COE Comparison

Compare BLRX & COE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • COE
  • Stock Information
  • Founded
  • BLRX 2003
  • COE 2011
  • Country
  • BLRX Israel
  • COE Singapore
  • Employees
  • BLRX N/A
  • COE N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • COE Other Consumer Services
  • Sector
  • BLRX Health Care
  • COE Real Estate
  • Exchange
  • BLRX Nasdaq
  • COE Nasdaq
  • Market Cap
  • BLRX 36.0M
  • COE 76.7M
  • IPO Year
  • BLRX 2011
  • COE 2016
  • Fundamental
  • Price
  • BLRX $0.20
  • COE $17.68
  • Analyst Decision
  • BLRX Strong Buy
  • COE
  • Analyst Count
  • BLRX 2
  • COE 0
  • Target Price
  • BLRX $5.50
  • COE N/A
  • AVG Volume (30 Days)
  • BLRX 1.7M
  • COE 12.6K
  • Earning Date
  • BLRX 11-25-2024
  • COE 12-13-2024
  • Dividend Yield
  • BLRX N/A
  • COE N/A
  • EPS Growth
  • BLRX N/A
  • COE N/A
  • EPS
  • BLRX N/A
  • COE N/A
  • Revenue
  • BLRX $21,991,000.00
  • COE $41,924,000.00
  • Revenue This Year
  • BLRX N/A
  • COE N/A
  • Revenue Next Year
  • BLRX N/A
  • COE N/A
  • P/E Ratio
  • BLRX N/A
  • COE N/A
  • Revenue Growth
  • BLRX N/A
  • COE 69.79
  • 52 Week Low
  • BLRX $0.19
  • COE $6.00
  • 52 Week High
  • BLRX $1.68
  • COE $19.75
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 25.94
  • COE 64.28
  • Support Level
  • BLRX $0.23
  • COE $15.45
  • Resistance Level
  • BLRX $0.56
  • COE $18.37
  • Average True Range (ATR)
  • BLRX 0.03
  • COE 1.23
  • MACD
  • BLRX 0.00
  • COE 0.36
  • Stochastic Oscillator
  • BLRX 11.82
  • COE 86.97

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About COE 51Talk Online Education Group

51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand.

Share on Social Networks: